Phagenesis Appoints Stephen Oesterle, MD, to Board of Directors
MedTechIndustryVeterantoSupportNextPhaseofU.S.GrowthandGlobal Expansion NASHVILLE, Tenn., April 29, 2026 /PRNewswire/ — Phagenesis, a commercial-stage company pioneering neuromodulation therapies for swallowing disorders, today announced the appointment of Stephen N. Oesterle, MD, to its Board of
